<DOC>
	<DOCNO>NCT02133534</DOCNO>
	<brief_summary>The purpose study see patient chronic kidney disease endothelial cell n't function properly , think marker cardiovascular risk . Endothelial cell line heart blood vessel . The investigator treat high cholesterol cholesterol-lowering drug ( atorvastatin , Lipitor ) . They determine cholesterol lower drug improve subject ' cholesterol well function endothelial cell .</brief_summary>
	<brief_title>The Effect Atorvastatin Endothelial Cell Dysfunction Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Stage 3 , 4 5 chronic kidney disease ( dialysis ) Hyperlipidemia require cholesterol lower therapy Aged 18 80 year old Ability provide inform consent Patients require multiple cholesterol reduce agent Patients neovascularization present , neoplasm , active wound , significant retinopathy Patients contraindication allergy statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic kidney disease</keyword>
	<keyword>High cholesterol</keyword>
</DOC>